市场调查报告书
商品编码
1496710
输液帮浦市场:按产品、模式、操作、应用和最终用户划分 - 全球预测,2024-2030 年Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球输液帮浦市场规模为180.3亿美元,2024年达192.5亿美元,预计2030年将达293.6亿美元,复合年增长率为7.21%。
输液帮浦是医疗设备,用于以受控和精确的方式将药物、营养液或水合液等液体输送到患者体内。这些帮浦设计用于在特定时间段内控制液体量,以确保准确给药和连续给药,具体取决于患者的治疗计划。输液帮浦通常用于医院、家庭护理机构和诊所,用于施用化疗药物、抗生素、止痛药、胰岛素或其他需要控制剂量的治疗药物。由于慢性病的日益普及和老年人口的不断增加,输液帮浦对方便的药物输送产生了迫切的需求。然而,输液帮浦用药错误的发生率、产品认证的严格监管要求以及输液帮浦设备的高成本阻碍了输液帮浦的发展。市场相关人员不断进行研究和开发,以提高输液帮浦的功能,同时提供具有成本效益的产品来解决这些限制。开拓具有增强安全功能和无线连接的智慧输液帮浦系统市场,为市场扩张提供了进一步的机会。输液帮浦与电子健康记录(EMR) 整合、使用者友善介面的开发和智慧警报等创新为输液帮浦带来了商机。
主要市场统计 | |
---|---|
基准年[2023] | 180.3亿美元 |
预测年份 [2024] | 192.5亿美元 |
预测年份 [2030] | 293.6亿美元 |
复合年增长率(%) | 7.21% |
区域洞察
美洲地区的特点是医疗基础设施强大、政府和多个主要企业的医疗保健支出高,推动了输液帮浦的成长和需求。此外,该地区致力于不断的产品创新,美国食品药物管理局(FDA) 等监管机构经常简化输液医疗设备的审批。此外,技术创新正在推动智慧技术和无线监控在输液设备中的整合。欧盟国家受益于确保输液设备品质和安全的高医疗保健标准和严格法规。成员国之间的合作以及对医疗保健技术的重大投资正在推动欧盟输液泵的研究和发展。欧盟对个人化医疗和居家输液治疗的需求也在增加。由于医疗保健成本不断上升以及人们对先进治疗方法的认识不断增强,亚太地区是一个快速成长的市场。中国、日本和印度等国家正在为该地区的扩张做出贡献。在中国,政府推动医疗保健现代化和扩大农村地区医疗服务覆盖范围的努力正在推动市场成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在输液帮浦市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对输液帮浦市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
战略分析和建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前输液帮浦市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[191 Pages Report] The Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024, at a CAGR 7.21% to reach USD 29.36 billion by 2030.
An infusion pump is a medical device used to deliver fluids, such as medications, nutrients, or liquids for hydration, into a patient's body in a controlled and precise manner. These pumps are designed to administer liquids in controlled amounts over specific periods, ensuring accurate dosing and continuous delivery as required by the patient's treatment plan. Infusion pumps are commonly used in hospitals, homecare settings, and clinics for delivering chemotherapy drugs, antibiotics, pain relievers, insulin, or other therapies requiring regulated administration. The increasing prevalence of chronic diseases and rising elderly population has established a significant need for infusion pumps for convenient delivery of medications. However, the occurrence of medication errors associated with infusion pumps, stringent regulatory requirements for product approval, and the high cost of infusion pump devices impede the development of infusion pumps. Market players are working on consistent R&D to improve the capabilities of infusion pumps while offering cost-effective products to address these limitations. Developing smart infusion pump systems with enhanced safety features and wireless connectivity presents additional opportunities for market expansion. Innovations such as integrating infusion pumps with electronic medical records (EMR), developing user-friendly interfaces, and smart alarms form opportunities for infusion pumps.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.03 billion |
Estimated Year [2024] | USD 19.25 billion |
Forecast Year [2030] | USD 29.36 billion |
CAGR (%) | 7.21% |
Regional Insights
The Americas region is characterized by a robust healthcare infrastructure, high government healthcare spending, and several key players, thereby driving the region's growth and demand for infusion pumps. The region is also involved in constant product innovations, and regulatory bodies such as the Food and Drug Administration (FDA) frequently streamline medical device approvals for infusion pumps. Furthermore, technological innovations have fuelled the integration of smart technologies and wireless monitoring in infusion devices. EU countries benefit from high healthcare standards and stringent regulations that ensure the quality and safety of infusion devices. Collaborations amongst member states and substantial investment in healthcare technology drive research and development for infusion pumps in the EU. The EU also experiences a rising demand for personalized medicine and home infusion therapy. The Asia-Pacific region is experiencing rapid market growth due to rising healthcare expenditures and increasing awareness of advanced therapeutic options. Countries such as China, Japan, and India contribute to the region's expansion. In China, government initiatives to modernize healthcare and expand rural access have bolstered the market growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Infusion Pumps Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Pumps Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Pumps Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
Fresenius Kabi has joined forces with the esteemed Mayo Clinic to implement the innovative Ivenix Infusion System. This state-of-the-art technology promises to revolutionize the infusion pump market by offering advanced safety features and an intuitive user interface to minimize medication errors and enhance patient care. The partnership highlights a collaborative commitment to clinical excellence, with the Ivenix system as a critical component in facilitating effective, real-time infusion data integration into electronic medical records (EMRs), thus enabling healthcare professionals to deliver high-quality, efficient patient care. [Published On: 2023-12-15]
Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
Tandem Diabetes Care has announced the launch of an advanced automated insulin delivery system. This new offering, combined with the Dexcom G7 continuous glucose monitoring (CGM) system, embodies a landmark in precision medicine, providing diabetes patients with a more autonomous and personalized treatment solution. Leveraging cutting-edge algorithms, the system automates insulin delivery with heightened accuracy, enhancing the user's control over their glucose levels without constant manual adjustments. The union of Tandem's automated insulin pump with Dexcom's CGM system is emblematic of the strides being made in the field of diabetes care, where innovation is directly translating to improved quality of life for individuals living with this chronic illness. [Published On: 2023-12-06]
Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
Monidor has enhanced its market presence by partnering with B. Braun SE to advance remote IV therapy monitoring. Leveraging Monidor's expertise and B. Braun's extensive distribution network, this partnership aims to optimize infusion therapies and improve patient care. Integrating Monidor's Monidrop device and the MoniView software with B. Braun's infusion systems facilitates accurate administration and oversight of IV fluids remotely, thus ensuring precise dosing and reducing the likelihood of manual errors. [Published On: 2023-08-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Pumps Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Avanos Medical, Inc., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Bio-x, Boston Scientific Corporation, Canadian Hospital Specialties Limited, Chemyx Inc., Epic Medical Pty Ltd., Fresenius Se & Co. KGaA, FUJIFILM Corporation, GE HealthCare Technologies Inc., ICU Medical, Inc., Insulet Corporation, Intera Oncology, Inc., Intuvie Holdings LLC, Ivenix, Inc., JMS Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Medline Industries, LP, Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Narang Medical Limited, New Era Pump Systems Inc., Nipro Corporation, Shenzhen MedRena Biotech Co., Ltd., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Siemens AG, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., and Ypsomed AG.
Market Segmentation & Coverage